>
Oxford Biodynamics logo

OBD - Oxford Biodynamics Share Price

73.6p -1.4  -1.9%

Last Trade - 3:31pm

Sector
Healthcare
Size
Small Cap
Market Cap £69.4m
Enterprise Value £58.5m
Revenue £456k
Position in Universe 1165th / 1826
Bullish
Bearish
Unlock OBD Revenue
Momentum
Relative Strength (%)
1m -20.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -40.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.70 1.09 1.18 1.19 0.91 0.46 5.79 -8.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 September 2020, OxfordBiodynamics PLC revenues decreased 50% to £456K. Net lossincreased 54% to £4.3M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Higher net loss reflectsStaff costs increase of 30% to £2.7M (expense), Research &development costs increase of 33% to £622K (expense),Exchange gains decrease from £141K (income) to £0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OBD Revenue Unlock OBD Revenue

Net Income

OBD Net Income Unlock OBD Revenue

Normalised EPS

OBD Normalised EPS Unlock OBD Revenue

PE Ratio Range

OBD PE Ratio Range Unlock OBD Revenue

Dividend Yield Range

OBD Dividend Yield Range Unlock OBD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
OBD EPS Forecasts Unlock OBD Revenue
Profile Summary

Oxford BioDynamics Plc is a biotechnology company, which is engaged in biomarker research and development. The Company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. Its geographical segments include UK and Malaysia. Its EpiSwitch is an industrial platform for the discovery, evaluation, validation and monitoring of a class of epigenetic biomarkers known as chromosome conformation signatures (CCSs). EpiSwitch is a biomarker technology platform that facilitates pharmaceutical and biotechnology companies in their therapeutic development programs and the development of companion diagnostics. The EpiSwitch technology has validated biomarkers in a range of diseases, including Alzheimer's disease, breast cancer, ulcerative colitis and liver cancer. Its service offering includes predictive biomarkers, prognostic biomarkers, residual disease monitoring biomarkers, diagnostic biomarkers and companion diagnostic biomarkers.

Directors
Last Annual September 30th, 2020
Last Interim September 30th, 2020
Incorporated April 25, 2007
Public Since December 6, 2016
No. of Shareholders: n/a
No. of Employees: 37
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 92,559,771
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OBD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OBD
Upcoming Events for OBD
Monday 14th June, 2021 Estimate
Half Year 2021 Oxford Biodynamics PLC Earnings Release
Frequently Asked Questions for Oxford Biodynamics
What is the Oxford Biodynamics share price?

As of 3:31pm, shares in Oxford Biodynamics are trading at 73.6p, giving the company a market capitalisation of £69.4m. This share price information is delayed by 15 minutes.

How has the Oxford Biodynamics share price performed this year?

Shares in Oxford Biodynamics are currently trading at 73.6p and the price has moved by 14.5% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Oxford Biodynamics price has moved by -7.1% over the past year.

What are the analyst and broker recommendations for Oxford Biodynamics?

Of the analysts with advisory recommendations for Oxford Biodynamics, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Oxford Biodynamics is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Oxford Biodynamics next release its financial results?

Oxford Biodynamics is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Oxford Biodynamics dividend yield?

Oxford Biodynamics does not currently pay a dividend.

Does Oxford Biodynamics pay a dividend?

Oxford Biodynamics does not currently pay a dividend.

When does Oxford Biodynamics next pay dividends?

Oxford Biodynamics does not currently pay a dividend.

How do I buy Oxford Biodynamics shares?

To buy shares in Oxford Biodynamics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Oxford Biodynamics?

Shares in Oxford Biodynamics are currently trading at 73.6p, giving the company a market capitalisation of £69.4m.

Where are Oxford Biodynamics shares listed? Where are Oxford Biodynamics shares listed?

Here are the trading details for Oxford Biodynamics:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: OBD
What kind of share is Oxford Biodynamics?

Based on an overall assessment of its quality, value and momentum, Oxford Biodynamics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Oxford Biodynamics share price forecast 2021?

Shares in Oxford Biodynamics are currently priced at 73.6p. At that level they are trading at 0.177% discount to the analyst consensus target price of 73.73.

Analysts covering Oxford Biodynamics currently have a consensus Earnings Per Share (EPS) forecast of 0.005 for the next financial year.

How can I tell whether the Oxford Biodynamics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oxford Biodynamics. Over the past six months, the relative strength of its shares against the market has been -1.12%. At the current price of 73.6p, shares in Oxford Biodynamics are trading at -7.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Oxford Biodynamics PE Ratio?

We were not able to find PE ratio data for Oxford Biodynamics.

Who are the key directors of Oxford Biodynamics?

Oxford Biodynamics's management team is headed by:

Alexandre Akoulitchev - CSO
Stephen Diggle - NED
Ewan Hunter - OTH
Paul Stockdale - CFO
David Holbrook - NID
Jon Anthony Joseph Burrows - CEO
Matthew Wakefield - NEC
Who are the major shareholders of Oxford Biodynamics?

Here are the top five shareholders of Oxford Biodynamics based on the size of their shareholding:

Millar (Christian Gurth Hoyer) Individual Investor
Percentage owned: 13.36% (12.4m shares)
Vulpes Investment Management Private Limited Hedge Fund
Percentage owned: 13.23% (12.2m shares)
Odey Asset Management LLP Investment Advisor/Hedge Fund
Percentage owned: 9.28% (8.59m shares)
Oxford University-Chancellor, Masters & Scholars Corporation
Percentage owned: 6.87% (6.36m shares)
Akoulitchev (Alexandre) Individual Investor
Percentage owned: 6.65% (6.15m shares)
Similar to OBD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.